Get started
Author

Fabien Colaone

Observed names: Colaone, Fabien, F. Colaone, FABIEN COLAONE
Institution: Neovacs (France)
Observed institutions: Sirtex (Germany), Neovacs (France)
ORCID: 0000-0002-9171-7861
Observed ORCIDs: 0000-0002-9171-7861, 0009-0000-4372-3792
OpenAlex ID: A5049835130
Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice
2021 · Eva Conde, Romain Bertrand, et al. · Nature Communications · 131
PDF
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
2016 · Julie Ducreux, Frédéric A. Houssiau, et al. · Rheumatology · 90
PDF
Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus
2011 · Alexis Mathian, Zahir Amoura, et al. · Annals of the Rheumatic Diseases · 50
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
2020 · Thomas Walter, Neil S. Hawkins, et al. · Journal of Cancer Research and Clinical Oncology · 35
PDF
Patient Preferences for Advanced Hepatocellular Carcinoma Treatment: A Multicountry Stated Preference Study
2021 · Siu Hing Lo, Rohini Sharma, et al. · Future Oncology · 23
PDF
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
2022 · Ion Agirrezabal, Victoria K. Brennan, et al. · Advances in Therapy · 19
PDF
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
2020 · Richard F. Pollock, Fabien Colaone, et al. · Journal of Medical Economics · 16
Cost–Utility Analysis of Selective Internal Radiation Therapy with Y-90 Resin Microspheres in Hepatocellular Carcinoma
2020 · Noemi Muszbek, Edit Remak, et al. · Future Oncology · 13
Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
2021 · Martin Killian, Fabien Colaone, et al. · Frontiers in Immunology · 12
PDF
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice
2025 · Eva Conde, Emma Lamanna, et al. · Science Translational Medicine · 9
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials
2020 · Richard F. Pollock, Victoria K. Brennan, et al. · Expert Review of Anticancer Therapy · 9
PDF
A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK
2020 · V. K. Brennan, F. Colaone, et al. · Journal of Medical Economics · 9
A vaccine targeting human IL ‐4 and IL ‐13 protects against asthma in humanized mice
2023 · Emma Lamanna, Eva Conde, et al. · Allergy · 5
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization
2021 · Richard F Pollock, Fabien Colaone, et al. · ClinicoEconomics and Outcomes Research · 3
PDF
Pcn98 Cost-comparison Analysis of Selective Internal Radiation Therapy (sirt) and Transarterial Chemoembolisation (tace) in Unresectable Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, R. Evans, et al. · Value in Health · 3
PDF
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)
2021 · Noemi Muszbek, Rachel Evans, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
PDF
Pcn83 Cost-utility Analyis of Selective Internal Radiation Therapy (sirt) With Y-90 Resin Microspheres in Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, E. Remak, et al. · Value in Health · 2
PDF
FRI0378 Potent, Broad, and Specific Neutralizing Capacities of Polyclonal Anti-Interferon Alpha Antibodies Induced by IFN Kinoid in SLE Patients
2014 · G. Grouard-Vogel, B.R. Lauwerys, et al. · Annals of the Rheumatic Diseases · 2
Pcn40 a Systematic Review and Exploratory Network Meta-analysis of Third-line Treatments for Metastatic Colorectal Cancer
2020 · T. Walter, N.S. Hawkins, et al. · Value in Health · 1
Pcn78 Changes in Health State Costs in Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, R. Evans, et al. · Value in Health · 1
PDF
Pcn21 Treatment Comparisons in Patients With Unresectable Heptocellular Carcinoma (hcc) Who Are Ineligible for Transarterial Chemoembolisation (tace)
2019 · R. Evans, N. Hawkins, et al. · Value in Health · 1
PDF
An Anti‐IL‐13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates
2025 · Aurélie Mougel, Katia Lemdani, et al. · Allergy
PDF
Efficacy and Safety of Bivalent IL-4/IL-13 mRNA Vaccine for Protection Against Allergic Asthma in Humanized Mice and Non-human Primates
2025 · L. Reber, K. Lemdani, et al. · American Journal of Respiratory and Critical Care Medicine
Evaluating the value of AI in lung imaging: a comprehensive review and evidence gap analysis from the healthcare authorities' and reimbursement perspective
2024 · Jana Keller, Fabien Colaone · European Respiratory Journal
Efficacy of an Anti-IL-4/IL-13 Vaccine in Models of Chronic Allergic Asthma in Mice
2022 · L.L. Reber, E. Conde, et al. · American Journal of Respiratory and Critical Care Medicine
Works count: 38
Citation count: 436
H-index: 9
I10-index: 9
Year
Topic
Type